Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) CTO Ming Yan sold 1,900 shares of the stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $7.00, for a total transaction of $13,300.00. Following the completion of the sale, the chief technology officer now owns 6,008,502 shares of the company's stock, valued at approximately $42,059,514. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Read this story
